Cembalta - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 60,216 | 360,887 | 28,800 | 225,800 | 12,380 | 126,102 | 197,850 | - |
| Profit before tax | -37,502 | 78,529 | -9,649 | 58,134 | 34,293 | 88,018 | 152,078 | 413 |
| Net profit | -37,502 | 74,995 | -9,649 | 58,134 | 32,828 | 83,617 | 144,474 | 388 |
| Equity | 153,358 | 228,353 | 118,704 | 176,838 | 209,666 | 293,283 | 437,752 | 438,139 |
| Liabilities | 516,014 | 487,643 | 592,510 | 685,494 | 684,365 | 747,100 | 299,895 | 203,981 |
| Non-current assets | 98,469 | 83,888 | 71,042 | 60,445 | 811 | 1 | 1 | 1 |
| Current assets | 570,903 | 630,706 | 638,758 | 801,803 | 893,220 | 1,040,382 | 737,646 | 642,053 |
| Total assets | 669,372 | 714,594 | 709,800 | 862,248 | 894,031 | 1,040,383 | 737,647 | 642,054 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 87 | 213 | 6,758 |
|
Financial indicators
|
||||||||
| Revenue change y/y | -75.5% | +499.3% | -92.0% | +684.0% | -94.5% | +918.6% | +56.9% | - |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -5.6% | 10.5% | -1.4% | 6.7% | 3.7% | 8.0% | 19.6% | 0.1% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | -24.5% | 32.8% | -8.1% | 32.9% | 15.7% | 28.5% | 33.0% | 0.1% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -62.3% | 20.8% | -33.5% | 25.7% | 265.2% | 66.3% | 73.0% | - |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | -62.3% | 21.8% | -33.5% | 25.7% | 277.0% | 69.8% | 76.9% | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 3.4 | 2.1 | 5.0 | 3.9 | 3.3 | 2.5 | 0.7 | 0.5 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 30,108 | 180,444 | 14,400 | 112,900 | 6,459 | 126,102 | 197,850 | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Cembalta - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-08-26 | 2026-08-26 | 240.84 |
| 2026-08-23 | 2026-08-23 | 240.84 |
| 2026-08-19 | 2026-08-19 | 240.84 |
| 2026-07-26 | 2026-07-26 | 703.78 |
| 2026-07-23 | 2026-07-25 | 709.39 |
| 2026-07-19 | 2026-07-22 | 703.78 |
| 2026-07-16 | 2026-07-17 | 221.80 |
| 2022-07-18 | 2022-08-15 | 0.27 |
| 2022-06-16 | 2022-07-17 | 0.29 |
| 2022-05-17 | 2022-06-12 | 0.31 |
| 2022-04-28 | 2022-05-15 | 0.31 |
| 2022-03-16 | 2022-03-17 | 348.85 |
Cembalta - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.